Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease

Overview of attention for article published in Nature Communications, April 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 16 X users

bluesky: 4 Bluesky users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 4 Bluesky posts from 4 Bluesky users, with an upper bound of 9,732 followers.

RP @shihcheng.bsky.social: A breakthrough dual inhibitor, SNT-8370, targets VAP-1 & MPO, key inflammatory enzymes. Promising preclinical results in combating inflammatory diseases. PMID:40210617, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s4146…

A breakthrough dual inhibitor, SNT-8370, targets VAP-1 & MPO, key inflammatory enzymes. Promising preclinical results in combating inflammatory diseases. PMID:40210617, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s41467-025-58454-6 #Medsky #Phar…

Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease www.nature.com/articles/s41... @naturecomms.bsky.social

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.